Exited position

Daniel Loeb’s Cvs Health Corp (CVS) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Third Point LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2005Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares1.58MHighest verified quarter-end share count
Quarters reported2Verified quarters with shares above zero
What happened?

Third Point LLC first reported Cvs Health Corp in Q3 2005. The latest verified relationship event shows that Third Point LLC sold the entire position in Q4 2024, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q4 2024
Sold the entire position−1.58M shares · No shares reported at quarter-end
Q3 2024
New position+1.58M shares · 1.58M shares reported
Filing context

Quarter-end price $62.88 · Estimated holding basis $62.88

Q4 2005
Sold the entire position−500.00K shares · No shares reported at quarter-end
Portfolio importance

How important was Cvs Health Corp in Third Point LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight1.3%Q3 2024
Last reported rank#25of 42 reported positions
Peak portfolio weight1.3%Q3 2024
Best historical rank#25Q3 2024
At peak importanceQ3 2024
CVS
1.3%
Largest holding
13.2%
Cross-investor discovery

Who else owns Cvs Health Corp?

Also reported by 2 other tracked investors in their latest verified filings.

Explore Cvs Health Corp across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$94.662026-09-11

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Third Point LLC’s Form 13F disclosures, not Daniel Loeb’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.